University of North Alabama

Open enrollment with a later-stage pipeline tilt

According to ClinicalTrials.gov-derived indexes, University of North Alabama sits in the upper half of US sponsors by registered trial count (#4,885 of 15,742 sponsors by registered trial count).

2 total trials 1 currently recruiting 1 completed later-stage tilt upper half by trial count

University of North Alabama: 2 sponsored US clinical trials, 1 recruiting.

University of North Alabama sponsors 2 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 1 completed. 1 of these trials are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Mental Fatigue, with 1 trials.

Mid-pack sponsor footprint

University of North Alabama is in the upper half of sponsors by trial count (#4,885 of 15,742 sponsors by registered trial count). Use the pipeline list and therapeutic areas to see what drives that mid-pack volume.

Where University of North Alabama enrollment is open (later-stage tilt)

1 recruiting of 2 indexed (50% open); 1 completed (50%).

Phase mix: 1 late (III/IV) vs 0 early (I/II) (later-stage heavy).

Top condition: Mental Fatigue (1 trial), 0 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

University of North Alabama: open-pipeline peers nationwide

Peers matched on 2 registered trials and 50% open enrollment, not the therapeutic-area sidebar.

University of North Alabama sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 1.522.533.544.5 0%20%40%60% Total trials Recruiting share University of North Alabama1200 Pharma1ST Biotherapeutics3 Waves Wellness3EO Health3ive Labs60 Degrees Pharmaceuticals7 Hills PharmaAbcentra
University of North Alabama sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

University of North Alabama sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 2 trials (± recruiting share)

Sponsors near 50% open enrollment (± trial volume)

What to do with this University of North Alabama page

2 registered trials is a research-attention snapshot, not an endorsement of University of North Alabama or any single study.

  • 1 of University of North Alabama's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Mental Fatigue is the condition University of North Alabama studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Mental Fatigue trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

University of North Alabama pipeline card: 2 registered trials from official public datasets.Report a data error.